Logo

BioFocus Granted ISO Certification Extension for Dutch Operations

Nov 29, 2006
NEW YORK (GenomeWeb News) — Galapagos’ BioFocus DPI division today said it has received an extension of its certification from the International Standards Organization for its target discovery operations in its Leiden, the Netherlands.
 
BioFocus, which specializes in adenoviral agents and compound libraries for drug development, said the certification covers the chemical and biological research services it offers to pharma, biotech and agrochem businesses.
 
This marks an extension of an ISO certification the company’s Cambridge, UK operation received in 2003.

Breaking News
The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.